Literature DB >> 17927299

Rivastigmine transdermal patch: in the treatment of dementia of the Alzheimer's type.

Lily P H Yang1, Gillian M Keating.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17927299     DOI： 10.2165/00023210-200721110-00007

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  21 in total

Review 1.  The magnitude of dementia occurrence in the world.

Authors:  Anders Wimo; Bengt Winblad; Hedda Aguero-Torres; Eva von Strauss
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

Review 2.  Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

Authors:  Peter Johannsen
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  The primary care of Alzheimer disease.

Authors:  Craig D Rubin
Journal:  Am J Med Sci       Date:  2006-12       Impact factor: 2.378

4.  Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.

Authors:  Bengt Winblad; Ariane K Kawata; Kathleen M Beusterien; Simu K Thomas; Anders Wimo; Roger Lane; Howard Fillit; Rafael Blesa
Journal:  Int J Geriatr Psychiatry       Date:  2007-05       Impact factor: 3.485

5.  Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.

Authors:  G Lefèvre; G Sedek; S S Jhee; M T Leibowitz; H-La Huang; A Enz; S Maton; L Ereshefsky; F Pommier; H Schmidli; S Appel-Dingemanse
Journal:  Clin Pharmacol Ther       Date:  2007-05-23       Impact factor: 6.875

Review 6.  Transdermal treatment options for neurological disorders: impact on the elderly.

Authors:  Lorenzo Priano; Maria Rosa Gasco; Alessandro Mauro
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

8.  Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease.

Authors:  S Muhlack; H Przuntek; T Müller
Journal:  Pharmacopsychiatry       Date:  2006-01       Impact factor: 5.788

9.  A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.

Authors:  Bengt Winblad; Jeffrey Cummings; Niels Andreasen; George Grossberg; Marco Onofrj; Carl Sadowsky; Stefanie Zechner; Jennifer Nagel; Roger Lane
Journal:  Int J Geriatr Psychiatry       Date:  2007-05       Impact factor: 3.485

10.  Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.

Authors:  Z Rakonczay
Journal:  Acta Biol Hung       Date:  2003
View more
  4 in total

Review 1.  Rivastigmine transdermal patch 13.3 mg/24 h: a review of its use in the management of mild to moderate Alzheimer's dementia.

Authors:  James E Frampton
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

2.  Once-daily transdermal rivastigmine in the treatment of Alzheimer's disease.

Authors:  Andreas Wentrup; Wolfgang H Oertel; Richard Dodel
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 3.  Cerebrolysin: a review of its use in dementia.

Authors:  Greg L Plosker; Serge Gauthier
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  The effect of hydroalcoholic extract of Ziziphora clinopodioides L. on spatial memory and neuronal density of hippocampal CA1 region in rats with sporadic Alzheimer's disease.

Authors:  Samaneh Sedighi; Maryam Tehranipour; Gholamhassan Vaezi; Vida Hojati; Hamid Hashemi-Moghaddam
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.